We have located links that may give you full text access.
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
Annals of Internal Medicine 2018 January 17
BACKGROUND: Five major organizations recently published guidelines for using statins to prevent atherosclerotic cardiovascular disease (ASCVD): in 2013, the American College of Cardiology/American Heart Association (ACC/AHA); in 2014, the United Kingdom's National Institute for Health and Care Excellence (NICE); and in 2016, the Canadian Cardiovascular Society (CCS), the U.S. Preventive Services Task Force (USPSTF), and the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS).
OBJECTIVE: To compare the utility of these guidelines for primary prevention of ASCVD.
DESIGN: Observational study of actual ASCVD events during 10 years, followed by a modeling study to estimate the effectiveness of different guidelines.
SETTING: The Copenhagen General Population Study.
PARTICIPANTS: 45 750 Danish persons aged 40 to 75 years who did not use statins and did not have ASCVD at baseline.
MEASUREMENTS: The number of participants eligible to use statins according to each guideline and the estimated number of ASCVD events that statins could have prevented.
RESULTS: The percentage of participants eligible for statins was 44% by the CCS guideline, 42% by ACC/AHA, 40% by NICE, 31% by USPSTF, and 15% by ESC/EAS. The estimated percentage of ASCVD events that could have been prevented by using statins for 10 years was 34% for CCS, 34% for ACC/AHA, 32% for NICE, 27% for USPSTF, and 13% for ESC/EAS.
LIMITATION: This study was limited to primary prevention in white Europeans.
CONCLUSION: Guidelines recommending that more persons use statins for primary prevention of ASCVD should prevent more events than guidelines recommending use by fewer persons.
PRIMARY FUNDING SOURCE: Copenhagen University Hospital.
OBJECTIVE: To compare the utility of these guidelines for primary prevention of ASCVD.
DESIGN: Observational study of actual ASCVD events during 10 years, followed by a modeling study to estimate the effectiveness of different guidelines.
SETTING: The Copenhagen General Population Study.
PARTICIPANTS: 45 750 Danish persons aged 40 to 75 years who did not use statins and did not have ASCVD at baseline.
MEASUREMENTS: The number of participants eligible to use statins according to each guideline and the estimated number of ASCVD events that statins could have prevented.
RESULTS: The percentage of participants eligible for statins was 44% by the CCS guideline, 42% by ACC/AHA, 40% by NICE, 31% by USPSTF, and 15% by ESC/EAS. The estimated percentage of ASCVD events that could have been prevented by using statins for 10 years was 34% for CCS, 34% for ACC/AHA, 32% for NICE, 27% for USPSTF, and 13% for ESC/EAS.
LIMITATION: This study was limited to primary prevention in white Europeans.
CONCLUSION: Guidelines recommending that more persons use statins for primary prevention of ASCVD should prevent more events than guidelines recommending use by fewer persons.
PRIMARY FUNDING SOURCE: Copenhagen University Hospital.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app